Fan F. Zhang

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.

S. Servaes, A. Naranjo, J. Maris, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study

A. Naranjo, S. Grupp, K. Matthay, 2021, Pediatric blood & cancer.